Introduction and aim:
Calcification is physiologically present in bone but also pathophysiologically in the vasculature, favouring cardiovascular diseases. Cardiovascular diseases are one of the most common causes of death within patients with chronic kidney disease and crucial for kidney transplantation (RTX) outcomes. The present knowledge about expression of calcification regulators in bone compared to vasculature is fragmentary. Our aim was to investigate these changes in the expression of calcification regulators (CR) during vascular calcification simultanously in bone and vasculature. Furthermore we tested the effect of systemic regulators of bone calcification in HEK293, HOS, EA.hy926 cells and HUVECs.
Conclusion:
We were able to demonstrate that changes in the expression of calcification regulators occur in the stage of vessel thickening even prior to vessel wall calcification. Changes in the expression of CRs in the vessels were counterbalanced in bone.
Material and methods:
Gene expression levels of OPG, RANKL, OPN, MGP, BSP-II and RUNX2 were determined in bone, aorta and arteria ilica externa tissue samples of 21 transplant donors. Realtime PCR was performed with predesigned TaqMan assays (Life Technologies) using the LC480 (Roche). Normalisation of the Cp values of CRs was done by division. Beta actin was used as housekeeping gene. The influence of PTH, 25(OH)-Vitamin-D3 and 1,25(OH) 2 -Vitamin-D3 on the expression of CR was tested in HEK293, HOS, EA.hy926 cells and HUVECs. In addition, serum measurements of PTH, Fetuin A, 25(OH)Vitamin-D3 and 1,25(OH)2-Vitamin-D3 were performed. 
Summary:
• The expression of calcification regulator genes (CR) changes in the three histological stages of atherosclerosis. • In the vessels, the expression of CR increases significantly after the first histological signs of calcification in the vessel wall but does not change significantly in further stages.
• At the same time, the expression of CR decreases in bone, starting in the stage of vessel wall thickening.
• The expression of Rankl and RUNX2 increases after induction with PTH in
HUVECs, but not in HEK293, HOS and EA.hy926 cells. • Serum levels of Fetuin A were significantly lower in stage 2 patients compared to the other stages (p=0.007). In RTX donors only atherosclerosis and no media sclerosis was present. The RTX donors were subgrouped using three histological stages of atherosclerosis (0) no changes, (1) intima thickening or (2) intima calcification. Patients' other tissue samples were subgrouped accordingly. 
